相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy
Theodore F. Tsai et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2011)
Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study
Nabihah Sachedina et al.
LANCET (2010)
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
Eric Plennevaux et al.
LANCET (2010)
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
Elizabeth Miller et al.
LANCET (2010)
SWINE FLU PANDEMIC What's Old Is New: 1918 Virus Matches 2009 H1N1 Strain
Jon Cohen
SCIENCE (2010)
Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: A prospective, open-label, multi-center trial
Chi-Eun Oh et al.
VACCINE (2010)
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months
Alfonso Carmona et al.
VACCINE (2010)
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
Claire S. Waddington et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States
Nicole E. Basta et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine.
Tristan W. Clark et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
Angelika Banzhoff et al.
PLOS ONE (2009)
Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
Timo Vesikari et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus
Yang Yang et al.
SCIENCE (2009)
Optimizing Influenza Vaccine Distribution
Jan Medlock et al.
SCIENCE (2009)
MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
T. Vesikari et al.
VACCINE (2009)
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
David I. Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1
Iain Stephenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Universal vaccination of children against influenza: Are there indirect benefits to the community? A systematic review of the evidence
R Jordan et al.
VACCINE (2006)
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine: A potential priming strategy
I Stephenson et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Confronting the avian influenza threat: vaccine development for a potential pandemic
I Stephenson et al.
LANCET INFECTIOUS DISEASES (2004)
分享论文
